scorecardresearch
Add as a preferred source on Google
Saturday, January 3, 2026
TopicIndian drugmaker

Topic: Indian drugmaker

Indian pharmas improved USFDA compliance, but cases of contamination grew 2014-2024—IPA report

The report, released at Global Pharmaceutical Quality Summit in Mumbai, draws comparison of incidences of ‘official action indicated' after USFDA inspections a decade apart.

Tax doctors on research grants by drugmakers, says govt panel reviewing pharma marketing practices

Five-member panel suggests doctors can't be given brand reminders exceeding Rs 1,000 each, Uniform Code of Pharmaceutical Marketing Practices to remain voluntary, but strengthened.

On Camera

Indian bureaucracy should be given incentives and rewards: MH Mody

Is there a place for a counter-bureaucracy, or a separate and competing bureaucracy to counterbalance the force of the executive’s bureaucracy, asked author MH Mody in 1980.

India’s urban co-op banks are turning the page—crisis to cautious revival, one metric at a time

With bad loans shrinking & capital buffers stronger, urban co-op banks’ new umbrella body NUCFDC is now prioritising rollout of digital transformation.

Greece looking at TATA’s WhAP infantry combat vehicle for army procurement

If deal goes through, Greece will be 2nd foreign country to procure vehicle. Morocco was first; TATA Group has set up manufacturing unit there with minimum 30 percent indigenous content.

A year-end Mea Culpa in National Interest—The Army-Islam combo doesn’t kill democracy

Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.